Victoria Lange

Victoria Lange

Auto-generated profile, based on publicly available information

Victoria Lange

Rapid Novor, Kitchener, Canada

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
TBThierry Le Bihan
Thierry Le Bihan
TDTeresa Nunez de Villavicencio Diaz
Teresa Nunez de Villavicencio Diaz
CRChelsea Reitzel
Chelsea Reitzel
VLVictoria Lange
Victoria Lange
MPMinyoung Park
Minyoung Park
BMBin Ma
Bin Ma
The antibody response to vaccination and infection is a key component of the immune response to pathogens. Sequencing of peripheral B cells may not represent the complete B cell receptor repertoire. Here we present a method for sequencing human plasma-derived polyclonal IgG using a combination of mass spectrometry and B-cell sequencing. We investigate the IgG response to the Moderna Spikevax COVID-19 vaccine. From the sequencing data of the natural polyclonal response to vaccination, we generate 12 recombinant antibodies. Six derived recombinant antibodies, including four generated with de novo protein sequencing, exhibit similar or higher binding affinities than the original natural polyclonal antibody. Neutralization tests reveal that the six antibodies possess neutralizing capabilities against the target antigen. This research provides insights into sequencing polyclonal IgG antibodies and the potential of our approach in generating recombinant antibodies with robust binding affinity and neutralization capabilities. Directly examining the circulating IgG pool is crucial due to potential misrepresentations by B-cell analysis alone.